Since STAT3, MYC, and EBNA1 are each essential for survival and proliferation of EBV-transformed and cancer cells, we tested the effects of the three inhibitors on cell viability and apoptosis in EBV+ HH514–16 BL cells. This evidence concerns the gene MYC and Burkitt lymphoma.